Centrexion Therapeutics Corp

Boston, MA

UEI
CUEAKMZEUNE7
CAGE
84FE9
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1 Boston St #3520, Boston, MA 02127, USA
Website
centrexion.com
Founded
2013
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel, non-opioid, non-addictive intrathecal therapy for the treatment of chronic pain UH3NS123965 National Institute of Neurological Disorders and Stroke (NIH) $29,234,629
Novel, non-opioid, non-addictive intrathecal therapy for the treatment of chronic pain - there is a consensus that… UG3NS123965 National Institute of Neurological Disorders and Stroke (NIH) $6,151,101

Quick answers

Is Centrexion Therapeutics Corp registered in SAM.gov?

Yes. Centrexion Therapeutics Corp's SAM.gov registration is active through September 22, 2027.

What is Centrexion Therapeutics Corp's most recent federal award?

Centrexion Therapeutics Corp's most recent federal grant award is Novel, non-opioid, non-addictive intrathecal therapy for the treatment of chronic pain (UH3NS123965), from National Institute of Neurological Disorders and Stroke (NIH), on September 30, 2021.

On GovTribe

See Centrexion Therapeutics Corp's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login